Merck & Co on Tuesday announced job and cost cuts that it said will save $3 billion a year, after it posted lower ...

The Gardasil human papillomavirus virus vaccine remains Merck’s second best-selling drug behind cancer treatment Keytruda.

Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to ...

Merck stock fell early Tuesday after Q2 results. The Dow Jones drugmaker plans for job cuts as part of restructuring ...

Merck Q2 earnings beat estimates but revenue fell short. Gardasil sales dropped while Keytruda and other treatments drove ...

Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said ...

Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed ...

Gardasil 9 is currently FDA-approved for people 9 through 26 years of age, but Merck is seeking FDA approval to extend its use in women and men ages 27 to 45 for the prevention of certain cancers ...

And the FDA: Of all of the reports in VAERS pertaining to Gardasil, approximately 13% describe syncope. The percentage is similar to reports of syncope for other adolescent vaccines.

Gardasil is claimed to contain an aluminum adjuvant, borax, Polysorbate 80, and genetically modified yeast. Some argue that the clinical trials focused on preventing cervical lesions instead of ...

Doctors say they doubt claims that Gardasil caused sisters' infertility. Nov. 8, 2013— -- Two Wisconsin women are in federal court today, alleging that Gardasil caused them to go into early ...

FDA panel recommends approval for Gardasil in boys but experts advise caution. Sept. 11, 2009 — -- Gynecologists and pediatricians largely supported a U.S. Food and Drug Administration ...